{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "RNA-Seq : Questions médicales les plus fréquentes",
"headline": "RNA-Seq : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les RNA-Seq : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-03",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "RNA-Seq"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Analyse de séquence d'ARN",
"url": "https://questionsmedicales.fr/mesh/D017423",
"about": {
"@type": "MedicalCondition",
"name": "Analyse de séquence d'ARN",
"code": {
"@type": "MedicalCode",
"code": "D017423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.393.760.710"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "RNA-Seq",
"alternateName": "RNA-Seq",
"code": {
"@type": "MedicalCode",
"code": "D000081246",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rency S Varghese",
"url": "https://questionsmedicales.fr/author/Rency%20S%20Varghese",
"affiliation": {
"@type": "Organization",
"name": "Genomics & Epigenomics Shared Resource, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA."
}
},
{
"@type": "Person",
"name": "Habtom W Ressom",
"url": "https://questionsmedicales.fr/author/Habtom%20W%20Ressom",
"affiliation": {
"@type": "Organization",
"name": "Genomics & Epigenomics Shared Resource, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. hwr@georgetown.edu."
}
},
{
"@type": "Person",
"name": "Qi Zhao",
"url": "https://questionsmedicales.fr/author/Qi%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou Medical University, Wenzhou, Zhejiang Province, China."
}
},
{
"@type": "Person",
"name": "Hongdi Cui",
"url": "https://questionsmedicales.fr/author/Hongdi%20Cui",
"affiliation": {
"@type": "Organization",
"name": "Oujiang Laboratory, Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China."
}
},
{
"@type": "Person",
"name": "Xu Yang",
"url": "https://questionsmedicales.fr/author/Xu%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Oujiang Laboratory, Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37175316",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28093906"
}
},
{
"@type": "ScholarlyArticle",
"name": "Versatile computer-aided design of free-form DNA nanostructures and assemblies.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37494445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/sciadv.adi0697"
}
},
{
"@type": "ScholarlyArticle",
"name": "Time efficiency and efficacy of a centralized computer-aided-design/computer-aided-manufacturing workflow for implant crown fabrication: A prospective controlled clinical study.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36252858",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jdent.2022.104332"
}
},
{
"@type": "ScholarlyArticle",
"name": "The clinical use of computer aided designed/computer aided manufactured titanium nitride coated implant abutments: Surgical and prosthetic considerations-A case series.",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36932837",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jerd.13035"
}
},
{
"@type": "ScholarlyArticle",
"name": "A comparative evaluation of marginal fit and microleakage of computer-aided design/computer-aided manufacturing-milled zirconia and prefabricated posterior occlusal veneers: An in vitrostudy.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/38946505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/jips.jips_346_23"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques génétiques",
"item": "https://questionsmedicales.fr/mesh/D005821"
},
{
"@type": "ListItem",
"position": 4,
"name": "Analyse de séquence",
"item": "https://questionsmedicales.fr/mesh/D017421"
},
{
"@type": "ListItem",
"position": 5,
"name": "Analyse de séquence d'ARN",
"item": "https://questionsmedicales.fr/mesh/D017423"
},
{
"@type": "ListItem",
"position": 6,
"name": "RNA-Seq",
"item": "https://questionsmedicales.fr/mesh/D000081246"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : RNA-Seq - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur RNA-Seq",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur RNA-Seq",
"description": "Comment l'RNA-Seq est-il utilisé dans le diagnostic ?\nQuels types de maladies peuvent être diagnostiqués par RNA-Seq ?\nL'RNA-Seq peut-il détecter des mutations ?\nQuelle est la précision de l'RNA-Seq pour le diagnostic ?\nL'RNA-Seq est-il standardisé pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur RNA-Seq",
"description": "Quels symptômes peuvent être analysés par RNA-Seq ?\nL'RNA-Seq peut-il identifier des biomarqueurs de symptômes ?\nPeut-on prédire des symptômes futurs avec RNA-Seq ?\nLes symptômes sont-ils liés à l'expression génique ?\nL'RNA-Seq peut-il aider à comprendre des symptômes complexes ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur RNA-Seq",
"description": "L'RNA-Seq peut-il aider à la prévention des maladies ?\nComment l'RNA-Seq contribue-t-il à la recherche préventive ?\nPeut-on utiliser RNA-Seq pour le dépistage précoce ?\nQuels types de prévention sont possibles avec RNA-Seq ?\nL'RNA-Seq peut-il aider à la prévention des cancers ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur RNA-Seq",
"description": "Comment l'RNA-Seq influence-t-il les traitements ?\nL'RNA-Seq peut-il guider le choix des médicaments ?\nQuels traitements peuvent être optimisés par RNA-Seq ?\nL'RNA-Seq peut-il aider à surveiller l'efficacité des traitements ?\nY a-t-il des traitements spécifiques basés sur RNA-Seq ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur RNA-Seq",
"description": "Quelles complications peuvent être détectées par RNA-Seq ?\nL'RNA-Seq peut-il prédire des complications ?\nComment RNA-Seq aide-t-il à gérer les complications ?\nY a-t-il des complications spécifiques liées à RNA-Seq ?\nL'RNA-Seq peut-il aider à éviter des complications ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur RNA-Seq",
"description": "Quels facteurs de risque peuvent être identifiés par RNA-Seq ?\nL'RNA-Seq peut-il révéler des risques pour des maladies spécifiques ?\nComment RNA-Seq aide-t-il à évaluer les facteurs de risque ?\nPeut-on utiliser RNA-Seq pour des études épidémiologiques ?\nL'RNA-Seq peut-il aider à identifier des risques environnementaux ?",
"url": "https://questionsmedicales.fr/mesh/D000081246?mesh_terms=Computer-Aided+Design&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'RNA-Seq est-il utilisé dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'identifier les niveaux d'expression des gènes et les mutations associées."
}
},
{
"@type": "Question",
"name": "Quels types de maladies peuvent être diagnostiqués par RNA-Seq ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour des cancers, des maladies génétiques et des infections virales."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il détecter des mutations ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut identifier des mutations dans les gènes exprimés, influençant le traitement."
}
},
{
"@type": "Question",
"name": "Quelle est la précision de l'RNA-Seq pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'RNA-Seq offre une haute précision pour quantifier l'expression génique."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq est-il standardisé pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe des protocoles standardisés, mais leur adoption varie selon les laboratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être analysés par RNA-Seq ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'RNA-Seq peut aider à comprendre les symptômes liés à des déséquilibres d'expression génique."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il identifier des biomarqueurs de symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut révéler des biomarqueurs associés à des symptômes spécifiques de maladies."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes futurs avec RNA-Seq ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'RNA-Seq peut aider à prédire des symptômes en analysant les profils d'expression génique."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils liés à l'expression génique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des variations dans l'expression génique peuvent être corrélées à des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à comprendre des symptômes complexes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet d'analyser des réseaux de gènes impliqués dans des symptômes complexes."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut identifier des facteurs de risque génétiques, permettant des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment l'RNA-Seq contribue-t-il à la recherche préventive ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'étudier les mécanismes moléculaires sous-jacents aux maladies pour mieux les prévenir."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser RNA-Seq pour le dépistage précoce ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour le dépistage précoce de certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "Quels types de prévention sont possibles avec RNA-Seq ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention ciblée et la surveillance des individus à risque sont possibles grâce à RNA-Seq."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à la prévention des cancers ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut identifier des biomarqueurs de risque pour des interventions préventives."
}
},
{
"@type": "Question",
"name": "Comment l'RNA-Seq influence-t-il les traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet de personnaliser les traitements en fonction des profils d'expression génique."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il guider le choix des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il aide à identifier les médicaments les plus efficaces selon l'expression des gènes."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent être optimisés par RNA-Seq ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements du cancer et des maladies auto-immunes peuvent être optimisés grâce à RNA-Seq."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à surveiller l'efficacité des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet de suivre les changements d'expression génique en réponse aux traitements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques basés sur RNA-Seq ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées sont développées en fonction des résultats d'RNA-Seq pour certains cancers."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent être détectées par RNA-Seq ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut révéler des complications liées à des mutations génétiques ou à des déséquilibres d'expression."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il prédire des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aider à prédire des complications en analysant les profils d'expression génique."
}
},
{
"@type": "Question",
"name": "Comment RNA-Seq aide-t-il à gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'adapter les traitements en fonction des complications identifiées par l'analyse."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques liées à RNA-Seq ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont généralement liées à l'interprétation des données plutôt qu'à la technique elle-même."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à éviter des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant les risques, il peut contribuer à éviter certaines complications cliniques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque peuvent être identifiés par RNA-Seq ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut identifier des facteurs génétiques et environnementaux associés à des maladies."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il révéler des risques pour des maladies spécifiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut révéler des risques pour des maladies comme le cancer ou les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment RNA-Seq aide-t-il à évaluer les facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il analyse l'expression des gènes pour déterminer les facteurs de risque potentiels."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser RNA-Seq pour des études épidémiologiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est utilisé pour étudier les facteurs de risque dans des populations spécifiques."
}
},
{
"@type": "Question",
"name": "L'RNA-Seq peut-il aider à identifier des risques environnementaux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut révéler comment les facteurs environnementaux influencent l'expression génique."
}
}
]
}
]
}
The application of computational approaches in drug discovery has been consolidated in the last decades. These families of techniques are usually grouped under the common name of "computer-aided drug ...
Recent advances in structural DNA nanotechnology have been facilitated by design tools that continue to push the limits of structural complexity while simplifying an often-tedious design process. We r...
To assess time efficiency and the efficacy of the prosthetic manufacturing for implant crown fabrication in a centralized workflow applying computer aided design and computer aided manufacturing (CAD-...
Fifty-nine patients with one posterior implant each, were randomly allocated to either a centralized digital workflow (c-DW, test) or a laboratory digital workflow (l-DW, control). Patients were exclu...
At impression taking, 12 patients (c-DW) and 19 patients (l-DW) were included. The impression time was 9.4±3.5 min (c-DW) and 15.1 ± 4.6 min (l-DW) (p < 0.05). The laboratory operating time was 130 ± ...
The c-DW was more time efficient compared to the lab-DW and rendered a similar efficacy of prosthetic manufacturing....
To describe the clinical use of nitride-coated titanium CAD/CAM implant abutments in the maxillary esthetic zone in two patients with high esthetic and functional demands and, to highlight the advanta...
Due to the inherent mechanical and esthetic clinical challenges, single implant-supported reconstructions in the maxillary esthetic zone are a complex restorative treatment. While CAD/CAM technology h...
Two patients requiring a combined tooth-implant restorative treatment in the maxillary esthetic zone were treated using CAD/CAM nitride coated titanium implant abutments. The principal advantages of T...
Clinical reports and short term mechanical, biological and esthetic clinical outcomes indicate that CAD/CAM nitride coated titanium implant abutments can represent a predictable restorative alternativ...
The aim of this study was to compare the marginal fit of prefabricated occlusal veneers with computer-aided design/computer-aided manufacturing (CAD-CAM)-milled zirconia occlusal veneers in the poster...
Forty extracted human maxillary premolars were divided into two groups of 20 each. Group 1 was prepared to receive prefabricated occlusal veneers, and Group 2 was prepared to receive CAD-CAM-milled zi...
Prefabricated samples (Edelweiss) were selected for Group 1, whereas for Group 2, the tooth preparations were scanned, and occlusal veneers were fabricated using Exocad designing software and milling ...
Data collected were subjected to statistical analysis using SPSS 27.0. Intragroup and intergroup comparison was done using the Mann-Whitney U test. The Chi-square test was applied to check the depth o...
The marginal gap of zirconia occlusal veneers fabricated with CAD-CAM is higher compared to that of prefabricated occlusal veneers. Similarly, the depth of penetration of dye is higher in CAD-CAM-mill...
The marginal fit of prefabricated occlusal veneer is better than the marginal fit of zirconia occlusal veneers fabricated with CAD-CAM. Similarly, it can also be concluded that the microleakage of pre...
Ion channels play important roles in fundamental biological processes, such as electric signaling in cells, muscle contraction, hormone secretion, and regulation of the immune response. Targeting ion ...
BACKGROUND Miswak is a form of chewing stick used to clean teeth in different parts of the world, including Saudi Arabia. We present a description of the effects of miswak derivatives, namely toothpas...
With the acceleration of economic development, people put forward higher requirements for clothing style. In this context, the application of traditional patterns has good artistic effects, can show a...
In recent years, interest in wireframe DNA origami has increased, with different designs, software, and applications emerging at a fast pace. It is now possible to design a wide variety of shapes by s...